Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?

Journal of Urology

Volumn 169, Issue 6, 2003, Pages 2126-2128

  Mosharafa, Ashraf A ^a   Foster, Richard S ^a   Leibovich, Bradley C ^a   Johnson, Richard Bihrle Cynthia ^a   Donohue, John P ^a  

^a NONE

Author keywords

Lymph node dissection; Morbidity; Seminoma; Testicular neoplasms; Testis

Indexed keywords

ADULT; ARTICLE; ASCITES; BLEEDING; CANCER CHEMOTHERAPY; FISTULA; HUMAN; INFERIOR CAVA VEIN; KIDNEY INFARCTION; LUNG EMBOLISM; LUNG FIBROSIS; LYMPH NODE DISSECTION; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHRECTOMY; NEUROLOGICAL COMPLICATION; NON SEMINOMATOUS GERMINOMA; PANCREATITIS; PARAAORTIC LYMPH NODE; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY; SEMINOMA; URINARY TRACT INFECTION; URINE INCONTINENCE; WOUND INFECTION;

EID: 0038626293     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000060121.33899.4b     Document Type: Article

References (13)

1. Gospodarowicz, M. K., Sturgeon, J. F. G. and Jewett, M. A.: Early stage and advanced seminoma: role of radiation therapy, surgery, and chemotherapy. Semin Oncol, 25: 160, 1998
2. Frohlich, M. W. and Small, E. J.: Stage II nonseminomatous testis cancer: the roles of primary and adjuvant chemotherapy. Urol Clin North Am, 25: 451, 1998
3. Herr, H. W., Sheinfeld, J., Puc, H. S., Heelan, R., Bajorin, D. F., Mencel, P. et al: Surgery for a post-chemotherapy residual mass in seminoma. J Urol, 157: 860, 1997
4. Motzer, R. J., Bosl, G., Heelan, R., Fair, W., Whitmore W., Sogani, P. et al: Residual mass: and indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J Clin Oncol, 5: 1064, 1987
5. Kamat, M. R., Kulkarni, J. N., Tongaonkar, H. B. and Ravi, R.: Value of retroperitoneal lymph node dissection in advanced testicular seminoma. J Surg Oncol, 51: 65, 1992
6. Hofmockel, G., Gruss, A. and Theiss, M.: Chemotherapy in advanced seminoma and the role of postcytostatic retroperitoneal lymph node dissection. Urol Int, 57: 38, 1996
7. Loehrer, P., Birch, R., Williams, S. D., Greco, F. A. and Einhorn, L. H.: Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience. J Clin Oncol, 5: 1212, 1987
8. Schultz, S. M., Einhorn, L. H., Conces, D. J., Jr., Williams, S. D. and Loehrer, P. J.: Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol, 7: 1497, 1989
9. Herr, H. W. and Bosl, G.: Residual mass after chemotherapy for seminoma: changing concepts of management. J Urol, 137: 1234, 1987
10. Bajorin, D. F., Herr, H., Motzer, R. J. and Bosl, G. J.: Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors. Semin Oncol, 19: 148, 1992
11. Sagalowsky, A. I., Ewalt, D. H., Molberg, K. and Peters, P. C.: Predictors of residual mass histology after chemotherapy for advanced testis cancer. Urology, 35: 537, 1990
12. Friedman, E. L., Garnick, M. B., Stomper, P. C., Mauch, P. M., Harrington, D. P. and Richie, J. P.: Therapeutic guidelines and results in advanced seminoma. J Clin Oncol, 3: 1325, 1985
13. Fossa, S. D., Borge, L., Aass, N., Johannessen, N. B., Stenwig, A. E. and Kaalhus, O.: The treatment of advanced metastatic seminoma: experience in 55 cases. J Clin Oncol, 5: 1071, 1987